Team

With over 25 years of global experience, more specifically in the development and marketing of breakthrough innovations in the cardiovascular field, Soad brings an extensive experience and a proven ability in leading innovative companies through rapid development and growth phases. She recently co-founded and served as CEO of T-Heart. Prior to this, Soad held several executive and senior management positions in various MedTech companies ranging from start-ups to multinational corporations. Soad holds an MBA in international business and a biomedical engineering degree.

Helmine has extensive experience in coordinating and managing clinical trials within the medical device industry. She has held various positions with CRO's, large device manufacturers and start-ups. She also co-founded Beltas Ltd, a New Zealand-based clinical research organization. Prior to Novostia, she was Head of Clinical at Acorai, a Swedish startup where she managed their global study of a heart failure device with sites in the US, UK and EU. 

Helmine holds a bachelor's degree in nursing from the University of Applied Sciences Utrecht, The Netherlands. She began her career as a monitor with Cardialysis, a Dutch research organization in the field of cardiovascular research. 
 

Felix is a mechanical engineer dedicated to the development and optimization of industrial processes. He has gained an extensive experience in medical device manufacturing thanks to Johnson & Johnson, Endosense, acquired by St. Jude Medical, and Symetis, the company behind the development of the TAVI bioprosthesis, acquired by Boston Scientific.

Felix holds a Master of Science degree from Arts et Métiers ParisTech, with further training in finance and leadership from INSEAD and a Lean Six sigma Black Belt certificate.

Felix joined Novostia in the summer of 2022 as Product and Process Development Manager with the mission of coordinating the outsourced activities in view of the first human implantations and further CE marking and FDA approval. In addition, he has the key role of developing additional valve sizes and accessories proprietary to Novostia in order to accelerate and scale up clinical trials.

Felix brings to Novostia his technical expertise in various manufacturing processes, his knowledge of the medical device manufacturing players and his expertise in the regulation of Class III devices in the EU and US. His previous work experience provides him with a comprehensive overview and a deep understanding of the steps required to bring a device to market.